Abstract
What's Next in CML - a Prospective Study Evaluating Sanger Sequencing and Next Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain (KD) Mutation Screening
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have